| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.47 | 0.0007 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.23 | 0.003 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.007 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.097 | 0.007 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.086 | 0.009 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.13 | 0.009 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.41 | 0.01 |